Unique ID issued by UMIN | UMIN000019676 |
---|---|
Receipt number | R000022737 |
Scientific Title | The double blind, placebo controlled trial of modafinil for excessive daytime sleepiness in Parkinson's disease |
Date of disclosure of the study information | 2015/11/10 |
Last modified on | 2019/03/25 13:28:21 |
The double blind, placebo controlled trial of modafinil for excessive daytime sleepiness in Parkinson's disease
The double blind, placebo controlled trial of modafinil for excessive daytime sleepiness in Parkinson's disease
The double blind, placebo controlled trial of modafinil for excessive daytime sleepiness in Parkinson's disease
The double blind, placebo controlled trial of modafinil for excessive daytime sleepiness in Parkinson's disease
Japan |
Parkinson's disease
Neurology |
Others
NO
Our purpose of this trial is to assess whether modafinil improve excessive daytime sleepiness in Parkinson's disease.
Safety,Efficacy
change of the Epworth Sleepiness Scale score
change of UPDRS part2 and 3 score, Mini Mental State Examination score, basic rhythm of brain waves and evaluation of caregivers
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Medicine |
taking modafinil (200 mg/day) after breakfast for 4 weeks, wash out for 2 weeks, taking matching placebo after breakfast for 4 weeks
taking matching placebo after breakfast for 4 weeks, wash out for 2 weeks, taking modafinil (200 mg/day) after breakfast for 4 weeks
20 | years-old | <= |
100 | years-old | > |
Male and Female
1: Patients with parkinson' disease
2: ESS total score >=8
1 : Patient who can not take orally.
2 : Patient with severe arrhythmia.
3 : Pregnant women and lactating patient
4 : Patient can not answer a questionnaire about excessive daytime sleepiness.
5 : Patient can not make regular clinic visits.
6 : Patient have methylphenidate or/and Pemoline.
7 : Patient is difficult to express one's agreement.
20
1st name | Rina |
Middle name | |
Last name | Ando |
Ehime University Graduate School of Medicine
Neurology and Clinical Pharmacology
791-0295
Tohon, Ehime 791-0295, Japan
089-960-5095
ando.rina.cn@ehime-u.ac.jp
1st name | Rina |
Middle name | |
Last name | Ando |
Ehime University Graduate School of Medicine
Neurology and Clinical Pharmacology
791-0295
Tohon, Ehime 791-0295, Japan
089-960-5095
ando.rina.cn@ehime-u.ac.jp
Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine
None
Other
Institutional Review Board ,Ehime University Hospital
Tohon, Ehime, Japan
089-960-5914
rinri@m.ehime-u.ac.jp
NO
2015 | Year | 11 | Month | 10 | Day |
Unpublished
14
There were no significant differences in ESS scores, daytime hypersomnia assessment by companion questionnaire, MMSE, and UPDRS part 3 between modiodal and placebo groups.
2019 | Year | 03 | Month | 25 | Day |
Completed
2015 | Year | 08 | Month | 01 | Day |
2015 | Year | 07 | Month | 27 | Day |
2015 | Year | 11 | Month | 10 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2015 | Year | 11 | Month | 07 | Day |
2019 | Year | 03 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022737
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |